Upregulated and downregulated glycoproteins in CD14+ monocytes after 24 h and 48 h of LPS treatment identified in this study represent likely candidates to characterize the tolerant reprogrammed cell state and might be tested in future studies with cells from patients with ET-related pathologies. This evidence concerns the gene CD14 and essential thrombocythemia.